Description
Objectives:
At the end of the session the learners will be able to:
1. Identify reason why and understanding of the microbiome is important for healthcare personnel
2. Identify the ways the microbiome changes during different disease states
3. Identify how the microbiome modulates treatment to disease, including cancer and the processing of medications
4. Identify methods to promote a healthy microbiome and the effectiveness of pre and probiotics
5. Discuss the current methods that the microbiome can be harnessed to treat disease
Description:
The human body is full of trillions of bacteria, viruses, and fungi, collectively known as the microbiome. What is less known by healthcare professionals is how the microbiome and alterations in it can affect a patient’s health status. Not only does it have a role in regulating the immune system during homeostasis, but it can also modulate the treatment of diseases, such as cancer, immunotherapy and even the processing of certain medications. How does the microbiome change during different diseases? Does dysbiosis drive disease or does disease drive dysbiosis? How well do pre and probiotics and general diet work to promote a healthy microbiome? Why is a healthy microbiome important in early life? What is the current evidence of how well the microbiome can be harnessed to treat disease? How effective is fecal transplantation and in what situations? How can microbial consortia be used? Join us for an illuminating discussion with Dr. Kathy McCoy, Ph.D. Improving your knowledge of the microbiome will help improve your patient care and your patient teaching.
Who Should Attend?:
• Nurses and HCP in Primary Care, Medical Surgical, Pediatrics, Gastrointestinal and Maternal Child Settings|
• Nurses and HCP in Oncology, Chronic Disease and Auto-immune Clinic Settings
• Dietitians, Nutritionists & Pharmacists in the above settings
• Occupational Health, Tele-health and Outpost Nurses
• Nurse Clinicians & Clinical Nurse Specialists, HC Managers and Nurse Educator
Dr. Kathy McCoy, Ph.D
Dr. Kathy McCoy is a Professor in the Department of Physiology and Pharmacology, Cumming School of Medicine, member of the Snyder Institute, Scientific Director of the International Microbiome Center, and holds the Killam Memorial Chair at the University of Calgary, Canada. Her research group uses germ-free and gnotobiotic models to investigate the cellular and molecular mechanisms by which the microbiome regulates host immunity and physiology. She is particularly interested in the dynamic interplay between the gut microbiota and the innate and adaptive immune systems. Her research aims to understand how exposure to intestinal microbes, particularly during early life, educates and regulates the mucosal, systemic and neuronal immune systems and how this can affect susceptibility to diseases, such as allergy, autoimmunity, and neurodevelopmental disorders. Her lab also investigates how the microbiome regulates the immune system throughout life with the aim to identify microbial therapies that can be employed to enhance current therapeutic approaches, such as in cancer.